Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

被引：83
作者：
Allen, U. [1 ]
Preiksaitis, J. [2 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Div Infect Dis, Toronto, ON M5G 1X8, Canada
[2] Univ Alberta, Dept Med, Edmonton, AB, Canada
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
B-lymphocyte; cytotoxic T lymphocyte surveillance; Epstein-Barr virus; posttransplant lymphoproliferation; primary infection; PTLD; CYTOTOXIC T-LYMPHOCYTES; EBV DNA LOAD; VIRAL LOAD; PERIPHERAL-BLOOD; DISEASE; RISK; THERAPY; MANAGEMENT; QUANTIFICATION; PREVENTION;
D O I：
10.1111/j.1600-6143.2009.02898.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：S87 / S96
页数：10
相关论文
共 61 条
[1]  
Allen UD, 2005, ADV EXP MED BIOL, V568, P25
[2]   Risk factors for post-transplant lymphoproliferative disorder in pediatric patients:: A case-control study [J].
Allen, UD ;
Farkas, G ;
Hébert, D ;
Weitzman, S ;
Stephens, D ;
Petric, M ;
Tellier, R ;
Ngan, B ;
Fecteau, A ;
West, L ;
Wasfy, S .
PEDIATRIC TRANSPLANTATION, 2005, 9 (04) :450-455
[3]  
Badley A D, 1996, Liver Transpl Surg, V2, P375, DOI 10.1002/lt.500020508
[4]   Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation [J].
Barshes, N. R. ;
Lee, T. R. ;
Goss, J. A. ;
Goodpastor, S. E. ;
Huls, M. H. ;
Rooney, C. M. ;
Karpen, S. J. ;
Wyllie, S. .
TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (02) :108-112
[5]   Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease [J].
Bianchi, Elena ;
Pascual, Manuel ;
Nicod, Marie ;
Delaloye, Angelika Bischof ;
Duchosal, Michel A. .
TRANSPLANTATION, 2008, 85 (05) :707-712
[6]   Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children [J].
Bingler, M. A. ;
Feingold, B. ;
Miller, S. A. ;
Quivers, E. ;
Michaels, M. G. ;
Green, M. ;
Wadowsky, R. M. ;
Rowe, D. T. ;
Webber, S. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (02) :442-445
[7]   qRituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation - Results of a phase II trial [J].
Blaes, AH ;
Peterson, BA ;
Bartlett, N ;
Dunn, DL ;
Morrison, VA .
CANCER, 2005, 104 (08) :1661-1667
[8]   Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease [J].
Burns, DM ;
Crawford, DH .
BLOOD REVIEWS, 2004, 18 (03) :193-209
[9]   Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression [J].
Caillard, S ;
Dharnidharka, V ;
Agodoa, L ;
Bohen, E ;
Abbott, K .
TRANSPLANTATION, 2005, 80 (09) :1233-1243
[10]   Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease [J].
Carpentier, L ;
Tapiero, B ;
Alvarez, F ;
Viau, C ;
Alfieri, C .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) :1853-1864
1234567